Skip to content
Mediacenter
Literature Database
Investor News
Careers
Get in Contact
International (English)
Remember my selection
Locale
USA (English)
German (Deutsch)
International (English)
International (English)
Remember my selection
Locale
USA (English)
German (Deutsch)
International (English)
Hotline
The Therapy
Background
Fields of application for the CytoSorb Therapy
Ticagrelor and Rivaroxaban
Therapeutic aspects
COVID-19
Global decision support
Product safety
Testimonials
CytoScore
The Studies
Multicenter Studies
Monocenter studies
The CytoSorb-Registry
Case of the Month Submission
The Adsorber
Setup of CytoSorb
Usage and Application
Technical data
Q&A
Events
Support
Mediacenter
Reimbursement & Coding of CytoSorb Therapy
Newsletter Registration
Hotline
About us
Corporation Management
CytoSorbents worldwide
Scientific partners
Careers
Get in Contact
Removal of Ticagrelor (Italian Subtitles)
The emergency surgical patient under Ticagrelor (German Subtitles)
Eliminación del ticagrelor
Removal of Ticagrelor (German Subtitles)
Reduction of inflammation in heart transplantation
Improved clinical outcome in ECMO patients
Enhanced hemodynamic and metabolic stability in aortic surgery
Faster control of refractory vasoplegic shock
Intraoperative use in endocarditis -The REMOVE trial
Ventajas frente a otros sistemas de soporte hepático
Previous
1
2
3
4
...
6
Next
The Therapy
Background
Fields of application for the CytoSorb Therapy
Ticagrelor and Rivaroxaban
Therapeutic aspects
COVID-19
Global decision support
Product safety
Testimonials
CytoScore
The Studies
Multicenter Studies
Monocenter studies
The CytoSorb-Registry
Case of the Month Submission
The Adsorber
Setup of CytoSorb
Usage and Application
Technical data
Q&A
Events
Support
Mediacenter
Reimbursement & Coding of CytoSorb Therapy
Newsletter Registration
Hotline
About us
Corporation Management
CytoSorbents worldwide
Scientific partners
Careers
Get in Contact
APPLY TODAY
JOBS
International (English)
Privacy Policy
Data protection
Disclaimer
Imprint
